<html>
  <div class="bg-white shadow-md rounded p-4">
    <h5 class="text-lg font-bold mb-2">Safety Information</h5>
    <p class="text-gray-600 mb-4">At Oncozen, we are committed to continuous innovation in the development of our oncology treatment. As part of this commitment, we prioritize the safety and well-being of patients.</p>
    <ul class="list-none mb-4">
      <li class="mb-2">
        <span class="text-gray-600">Adverse Reactions:</span>
        <span class="text-gray-900">The most common adverse reactions reported in clinical trials were fatigue, nausea, and diarrhea.</span>
      </li>
      <li class="mb-2">
        <span class="text-gray-600">Contraindications:</span>
        <span class="text-gray-900">Oncozen is contraindicated in patients with severe hypersensitivity to any component of the product.</span>
      </li>
      <li class="mb-2">
        <span class="text-gray-600">Warnings and Precautions:</span>
        <span class="text-gray-900">Monitor patients for signs of cardiac toxicity and hepatic impairment.</span>
      </li>
    </ul>
    <p class="text-gray-600 mb-4">For a comprehensive overview of Oncozen's safety profile, please refer to the full Prescribing Information.</p>
    <a href="#" class="text-blue-600 hover:text-blue-900 transition duration-300 ease-in-out">View Full Prescribing Information</a>
  </div>
</html>